These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Paget's disease of bone: diagnosis and management. Kanis JA, Evanson JM, Russell RG. Metab Bone Dis Relat Res; 1981; 3(4-5):219-30. PubMed ID: 6220190 [Abstract] [Full Text] [Related]
23. Beneficial effects of aminohexane diphosphonate in patients with Paget's disease of bone resistant to sodium etidronate. Delmas PD, Chapuy MC, Edouard C, Meunier PJ. Am J Med; 1987 Aug; 83(2):276-82. PubMed ID: 3113247 [Abstract] [Full Text] [Related]
24. Intravenous disodium etidronate therapy in Paget's disease of bone and hypercalcemia of malignancy. Effects on biochemical parameters and bone histomorphometry. Meunier PJ, Chapuy MC, Delmas P, Charhon S, Edouard C, Arlot M. Am J Med; 1987 Feb 23; 82(2A):71-8. PubMed ID: 3103438 [Abstract] [Full Text] [Related]
25. [Long-term follow-up of 88 patients with Paget's disease treated by discontinuous courses of low-dose disodium etidronate]. Ravault A, Meunier PJ. Rev Rhum Mal Osteoartic; 1989 Mar 15; 56(4):293-302. PubMed ID: 2496461 [Abstract] [Full Text] [Related]
26. Evaluation of sodium etidronate in the treatment of Paget's disease of bone. Osteitis deformans. Stein I, Shapiro B, Ostrum B, Beller ML. Clin Orthop Relat Res; 1977 Mar 15; (122):347-58. PubMed ID: 402246 [Abstract] [Full Text] [Related]
27. Sodium etidronate in the treatment of Paget's disease of bone. A study of long-term results. Khairi MR, Altman RD, DeRosa GP, Zimmermann J, Schenk RK, Johnston CC. Ann Intern Med; 1977 Dec 15; 87(6):656-63. PubMed ID: 412450 [Abstract] [Full Text] [Related]
30. [Osteolysis, then fracture of the femur in a Paget's disease patient treated with high-dose disodium etidronate]. Pinel B, Cambon C, Thomine JM, Cauvin M, Daragon A, Deshayes P. Rev Rhum Mal Osteoartic; 1984 Dec 15; 51(7-8):417-8. PubMed ID: 6436959 [No Abstract] [Full Text] [Related]
31. Treatment of Paget's disease with a diphosphonate (sodium etidronate). Smith R, Russell RG. Semin Drug Treat; 1972 Dec 15; 2(1):77-81. PubMed ID: 4558759 [No Abstract] [Full Text] [Related]
33. Comparative prospective, double-blind, multicenter study of the efficacy of tiludronate and etidronate in the treatment of Paget's disease of bone. Roux C, Gennari C, Farrerons J, Devogelaer JP, Mulder H, Kruse HP, Picot C, Titeux L, Reginster JY, Dougados M. Arthritis Rheum; 1995 Jun 15; 38(6):851-8. PubMed ID: 7779130 [Abstract] [Full Text] [Related]
35. A patient with Paget's disease of bone treated with etidronate disodium. Koga K, Kawasaki K, Kohno S, Yamada K, Itoh T, Nonaka K. Kurume Med J; 1998 Jun 15; 45(4):345-9. PubMed ID: 9914722 [Abstract] [Full Text] [Related]
36. [Treatment of Paget's disease of bone with ethane-1 hydroxy-1, 1 diphosphonate at low dosage (author's transl)]. Alexandre C, Chapuy MC, Bressot C, Vignon E, Arlot M, Mathieu L, Edouard C, Johnston CC, Meunier PJ. Nouv Presse Med; 1980 Nov 29; 9(45):3429-33. PubMed ID: 6777752 [Abstract] [Full Text] [Related]
37. Contrasting effects of intravenous and oral etidronate on vitamin D metabolism in man. Lawson-Matthew PJ, Guilland-Cumming DF, Yates AJ, Russell RG, Kanis JA. Clin Sci (Lond); 1988 Jan 29; 74(1):101-6. PubMed ID: 3123117 [Abstract] [Full Text] [Related]